Samsung Electronics America, Inc. and WellDoc, a digital therapeutic company, announced today that Samsung Health users now have access to a new consumer version of WellDoc’s digital platform known as the Diabetes Wellness Program (DWP). Samsung Health users now have access to a new Diabetes Wellness Program (DWP) available through the Samsung Health service that is powered by WellDoc’s platform used in its BlueStar® product. It is available to individuals in the United States with Samsung
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Why Did the Global Digital Health Market Strengthen During Q4 2017?
Healthcare innovation consultancy Enspektos, LLC, today released the latest edition of its quarterly study, digihealth impact trac. The report focuses on key Q4 2017 market themes and previews five digital health trends that will matter in 2018. The research reveals that telemedicine is having a far-reaching impact as adoption surges globally. Most importantly, telemedicine solutions are delivering economic benefits and re-shaping the patient-physician relationship, as clinicians learn what it
Read More
CTA, Personal Connected Health Alliance Partner on Digital Therapeutics Research
The Personal Connected Health Alliance (PCHAlliance) and Consumer Technology Association (CTA) Health and Fitness Technology Division has announced a new, strategic collaboration around digital therapeutics research. The strategic collaboration aims to understand the current demand, adoption and market trends related to digital therapeutics among patients and health care professionals alongside technology and pharmaceutical companies.Understanding Digital TherapeuticsThe field of digital
Read More
Led by Cigna, Omada Health Nabs $50M to Expand Digital Therapeutics for Chronic Disease
Omada Health, a digital health company that helps health plans and employers tackle type 2 diabetes and heart disease in the most engaging, effective, and scalable way possible has raised $50 million in funding led by Cigna. The round also included participation and U.S. Venture Partners, Andreessen Horowitz, Norwest Venture Partners, Humana, Kaiser Permanente Ventures, Providence Ventures, dRx Capital, GE Ventures, Civilization Ventures and Sanofi Genzyme BioVentures.Omada also announced that
Read More